Randomized phase II designs in cancer clinical trials : Current status and future directionsLEE, J. Jack; LEI FENG.Journal of clinical oncology. 2005, Vol 23, Num 19, pp 4450-4457, issn 0732-183X, 8 p.Article

Comparison of Bayesian sample size criteria: ACC, ALC, and WOCJINGCAO; LEE, J. Jack; ALBER, Susan et al.Journal of statistical planning and inference. 2009, Vol 139, Num 12, pp 4111-4122, issn 0378-3758, 12 p.Article

Phase II trial design with Bayesian adaptive randomization and predictive probabilityGUOSHENG YIN; NAN CHEN; LEE, J. Jack et al.Applied statistics. 2012, Vol 61, Num 2, pp 219-235, issn 0035-9254, 17 p.Article

Reducing the risk of chemoprevention : Defining and targeting high risk-2005 AACR cancer research and prevention foundation award lectureLIPPMAN, Scott M; LEE, J. Jack.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 2893-2903, issn 0008-5472, 11 p.Article

Worth Adapting? Revisiting the Usefulness of Outcome-Adaptive RandomizationLEE, J. Jack; NAN CHEN; GUOSHENG YIN et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4498-4507, issn 1078-0432, 10 p.Article

Model diagnostic tests for selecting informative correlation structure in correlated dataANNIE QU; LEE, J. Jack; LINDSAY, Bruce G et al.Biometrika. 2008, Vol 95, Num 4, pp 891-905, issn 0006-3444, 15 p.Article

Uniform power method for sample size calculation in historical control studies with binary responseLEE, J. Jack; TSENG, Chi-Hong.Controlled clinical trials. 2001, Vol 22, Num 4, pp 390-400, issn 0197-2456Article

Dose Escalation Methods in Phase I Cancer Clinical TrialsLE TOURNEAU, Christophe; LEE, J. Jack; SIU, Lillian L et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 10, pp 708-720, issn 0027-8874, 13 p.Article

Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non―Small-Cell Lung CancerHUA BAI; ZHIJIE WANG; JIANCHUN DUAN et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3077-3083, issn 0732-183X, 7 p.Article

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA MutationsJANKU, Filip; WHELER, Jennifer J; LUTHRA, Rajyalakshmi et al.Journal of clinical oncology. 2012, Vol 30, Num 8, pp 777-782, issn 0732-183X, 6 p.Article

Chemoradiotherapy With or Without AE-941 in Stage III Non-Small Cell Lung Cancer: A Randomized Phase III TrialLU, Charles; LEE, J. Jack; SAXMAN, Scott et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 12, pp 859-865, issn 0027-8874, 7 p.Article

Randomized Trial of 13 -as Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral PremalignancyPAPADIMITRAKOPOULOU, Vassiliki A; LEE, J. Jack; LIPPMAN, Scott M et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 599-604, issn 0732-183X, 6 p.Article

Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinomaBREWSTER, Abenaa M; LEE, J. Jack; LIPPMAN, Scott M et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 1974-1978, issn 0732-183X, 5 p.Article

Repair Capacity for UV Light-Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor ProgressionWANG, Li-E; CHUNYING LI; PRIETO, Victor G et al.Clinical cancer research. 2007, Vol 13, Num 21, pp 6532-6539, issn 1078-0432, 8 p.Article

Fenretinide activity in retinoid-resistant oral leukoplakiaLIPPMAN, Scott M; LEE, J. Jack; PAPADIMITRAKOPOULOU, Vassiliki et al.Clinical cancer research. 2006, Vol 12, Num 10, pp 3109-3114, issn 1078-0432, 6 p.Article

Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene : a meta-analysis of multiple cancer typesEWART-TOLAND, Amanda; QI DAI; DONGXIN LIN et al.Carcinogenesis (New York. Print). 2005, Vol 26, Num 8, pp 1368-1373, issn 0143-3334, 6 p.Article

Mortality risk from squamous cell skin cancerCLAYMAN, Gary L; LEE, J. Jack; KRIPKE, Margaret L et al.Journal of clinical oncology. 2005, Vol 23, Num 4, pp 759-765, issn 0732-183X, 7 p.Article

Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implicationTAI, Shyh-Kuan; LEE, Janet I; KIAN ANG, K et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5554-5557, issn 1078-0432, 4 p.Article

Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classificationEL-NAGGAR, Adel K; KIM, Hyung W; CLAYMAN, Gary L et al.Oncogene (Basingstoke). 2002, Vol 21, Num 53, pp 8206-8219, issn 0950-9232, 14 p.Article

Phase I and pharmacokinetic study of exatecan mesylate (DX-8951F) : A novel camptothecin analogROYCE, Melanie E; HOFF, Paulo M; DUMAS, Pamela et al.Journal of clinical oncology. 2001, Vol 19, Num 5, pp 1493-1500, issn 0732-183XArticle

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancerPOLLACK, Alan; ZAGARS, Gunar K; SMITH, Lewis G et al.Journal of clinical oncology. 2000, Vol 18, Num 23, pp 3904-3911, issn 0732-183XArticle

VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2-Targeted TherapyRIQUELME, Erick; SURAOKAR, Milind; WAUN KI HONG et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3849-3861, issn 1078-0432, 13 p.Article

Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non―Small Cell Lung Cancer Patients after Definitive Surgery by Expression ProfilingKADARA, Humam; LI SHEN; BEHRENS, Carmen et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 1, pp 8-17, issn 1940-6207, 10 p.Article

ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non―Small Cell Lung CancerKABBOUT, Mohamed; GARCIA, Melinda M; BEHRENS, Carmen et al.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3383-3395, issn 1078-0432, 13 p.Article

Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell CarcinomaZHONG, Lai-Ping; ZHANG, Chen-Ping; WANG, Li-Zhen et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 744-751, issn 0732-183X, 8 p.Article